نتائج البحث - "Lucie Sramkova"

المصدر: Eckert, C, Parker, C, Moorman, A V, Irving, J A, Kirschner-Schwabe, R, Groeneveld-Krentz, S, Révész, T, Hoogerbrugge, P, Hancock, J, Sutton, R, Henze, G, Chen-Santel, C, Attarbaschi, A, Bourquin, J-P, Sramkova, L, Zimmermann, M, Krishnan, S, von Stackelberg, A & Saha, V 2021, ' Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials ', European Journal of Cancer, vol. 151, pp. 175-189 . https://doi.org/10.1016/j.ejca.2021.03.034Test

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Neoplasm, Residual, Time Factors, medicine.medical_treatment, High-risk, Gene Dosage, Graft vs Host Disease, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Targeted therapy, 0302 clinical medicine, Recurrence, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, 1306 Cancer Research, Child, Clinical Trials as Topic, Manchester Cancer Research Centre, Acute lymphoblastic leukaemia, Hematopoietic Stem Cell Transplantation, Stem cell transplantation, Progression-Free Survival, medicine.anatomical_structure, Child, Preschool, 030220 oncology & carcinogenesis, Disease Progression, 2730 Oncology, Female, medicine.medical_specialty, Adolescent, T cell, Karyotype, 610 Medicine & health, Outcomes, Risk Assessment, Disease-Free Survival, 03 medical and health sciences, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Internal medicine, Biomarkers, Tumor, medicine, Humans, B cell, Proportional hazards model, business.industry, Minimal residual disease, ResearchInstitutes_Networks_Beacons/mcrc, Transplantation, Clinical trial, 030104 developmental biology, 10036 Medical Clinic, Mutation, Lymphoblastic leukaemia, business

وصف الملف: application/pdf; PIIS095980492100201X.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704d729c17931425043d5d11dbce2418Test
https://doi.org/10.1016/j.ejca.2021.03.034Test

7

Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group

المؤلفون: Claudia Rossig, Ursula Creutzig, Beate Lerius, Bernd Gruhn, Martin Zimmermann, Jean-Pierre Bourquin, Naghmeh Niktoreh, Lucie Sramkova, Dirk Reinhardt, Michael Dworzak, Mareike Rasche, Gabriele Escherich

المساهمون: University of Zurich, Rasche, Mareike

المصدر: Haematologica

وصف الملف: 1040120.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c831a381f371e285099ad962cba4d964Test
https://doi.org/10.3324/haematol.2018.191841Test

8

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols

المساهمون: Cario, G, Leoni, V, Conter, V, Attarbaschi, A, Zaliova, M, Sramkova, L, Cazzaniga, G, Fazio, G, Sutton, R, Elitzur, S, Izraeli, S, Lauten, M, Locatelli, F, Basso, G, Buldini, B, Bergmann, A, Lentes, J, Steinemann, D, Göhring, G, Schlegelberger, B, Haas, O, Schewe, D, Buchmann, S, Moericke, A, White, D, Revesz, T, Stanulla, M, Mann, G, Bodmer, N, Arad-Cohen, N, Zuna, J, Valsecchi, M, Zimmermann, M, Schrappe, M, Biondi, A

المصدر: Haematologica

مصطلحات موضوعية: Oncology, medicine.medical_specialty, ABL-class fusion, medicine.drug_class, medicine.medical_treatment, Fusion Proteins, bcr-abl, antineoplastic combined chemotherapy protocols, B-lymphocytes, child, Hematopoietic stem cell transplantation, Tyrosine-kinase inhibitor, Recurrence, Internal medicine, hemic and lymphatic diseases, medicine, Humans, Cumulative incidence, Pediatric Acute Lymphoblastic Leukemia, Child, Chemotherapy, B-Lymphocytes, ABL, business.industry, Hematology, Articles, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Prognosis, Tyrosin Kinase Inhibitors, Minimal residual disease, Transplantation, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, Stem cell, business, ALL

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b40a393e592341af6a466b31ee735aaTest
http://hdl.handle.net/10281/270087Test

9

Failures and Successes in Pediatric Patients with Acute Myeloid Leukemia with First Relapse: A Large International Report on Current Treatment Strategies and Outcome

المصدر: Blood. 136:6-7

مصطلحات موضوعية: medicine.medical_specialty, Down syndrome, Multivariate analysis, business.industry, Proportional hazards model, Immunology, Myeloid leukemia, Subgroup analysis, Cell Biology, Hematology, medicine.disease, Biochemistry, First relapse, Cog, Internal medicine, Cohort, medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::559424b70a219897dabf3bb1b1e253aeTest
https://doi.org/10.1182/blood-2020-141774Test

10

Rational Response-Adapted Risk Stratification and Treatment for Children with Late Bone Marrow Relapses of B-Cell Precursor Acute Lymphoblastic Leukaemia: A Report from the ALL-REZ BFM Trial Group

المؤلفون: Günter Henze, Arend von Stackelberg, Jean-Pierre Borquin, Lucie Sramkova, Renate Kirschner-Schwabe, Renate Panzer-Grümayer, Kathy Astrahantseff, Cornelia Eckert, Christina Peters, Arndt Borkhardt, Gunnar Cario, Gabriele Escherich, Nikola Hagedorn, Stefanie Groeneveld-Krentz, Peter Bader, Christiane Chen-Santel, Andishe Attarbaschi

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Proportional hazards model, Disease, Minimal residual disease, body regions, Transplantation, Dissection, Haematopoiesis, medicine.anatomical_structure, Informed consent, hemic and lymphatic diseases, Internal medicine, medicine, Bone marrow, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2b0e607855660fb41564506b7eb46e77Test
https://doi.org/10.2139/ssrn.3388826Test

تنقيح النتائج